Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis

In the phase 2 clinical study, topical delgocitinib, a novel Janus kinase inhibitor, improved clinical signs and symptoms in pediatric patients with atopic dermatitis and was well tolerated.

Source: Journal of Allergy and Clinical Immunology - August 15, 2019 Category: Allergy & Immunology Authors: Hidemi Nakagawa, Osamu Nemoto, Atsuyuki Igarashi, Hidehisa Saeki, Manabu Oda, Kenji Kabashima, Takeshi Nagata Source Type: research